4//SEC Filing
Nofi Michael 4
Accession 0001104659-23-002314
CIK 0001773427other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:00 PM ET
Size
11.5 KB
Accession
0001104659-23-002314
Insider Transaction Report
Form 4
Nofi Michael
Chief Accounting Officer
Transactions
- Award
Common Stock
2023-01-05+9,713→ 18,047 total - Award
Stock Option (Right to Buy)
2023-01-05+30,000→ 30,000 totalExercise: $27.64Exp: 2033-01-05→ Common Stock (30,000 underlying) - Tax Payment
Common Stock
2023-01-06$27.52/sh−783$21,548→ 17,264 total - Award
Stock Option (Right to Buy)
2023-01-05+35,000→ 35,000 totalExercise: $27.64Exp: 2033-01-05→ Common Stock (35,000 underlying)
Footnotes (4)
- [F1]This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty three percent (33%) to vest on January 5, 2024, another thirty three percent (33%) to vest on January 5, 2025 and the remaining thirty four percent (34%) to vest on January 5, 2026, such that the restricted stock awards are fully vested on January 5, 2026.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.
- [F3]This option shall vest in 48 equal monthly installments subject to continued service to the Issuer by the Reporting Person.
- [F4]Twenty-five percent (25%) of this option shall vest and become exercisable on January 5, 2024, with the remaining seventy-five percent (75%) to vest in thirty-six (36) equal monthly installments thereafter subject to continued service to the Issuer by the Reporting Person.
Documents
Issuer
SpringWorks Therapeutics, Inc.
CIK 0001773427
Entity typeother
Related Parties
1- filerCIK 0001705477
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 5:00 PM ET
- Size
- 11.5 KB